MASIMO CORP (MASI)
Sector: Health Care
Sector: Health Care
MASIMO CORP - Executive Compensation
Former Chief Executive Officer and Chairman of the Board
Executive Compensation
Joe Kiani is a prominent figure in the medical technology industry, best known for his role as the former Chief Executive Officer and Chairman of the Board at Masimo Corporation. Born on September 16, 1964, in Shiraz, Iran, Kiani moved to the United States at the age of nine. He pursued higher education at San Diego State University, where he earned a Bachelor of Science degree in Electrical Engineering. His career in medical technology began when he joined Masimo in 1989, a company he co-founded with Mohamed Diab. Under his leadership, Masimo grew from a small startup into a global leader in noninvasive patient monitoring technologies. As CEO, Kiani played a pivotal role in steering Masimo towards significant achievements and innovations. One of his most notable contributions was the development of Masimo SET pulse oximetry, a technology that significantly improved the accuracy of oxygen saturation measurements, particularly in challenging conditions such as patient motion and low perfusion. This breakthrough not only solidified Masimo's position in the market but also had a profound impact on patient care worldwide. Kiani's leadership also saw Masimo expand its product portfolio to include technologies for monitoring other vital signs, such as brain function and respiratory parameters, further enhancing the company's reputation as an innovator in healthcare technology. In addition to his role at Masimo, Joe Kiani is recognized for his contributions to the broader community and philanthropy. He has been actively involved in initiatives aimed at improving healthcare access and quality, particularly for underserved populations. Kiani's vision and dedication have earned him numerous accolades, including the Ernst & Young Entrepreneur of the Year Award and the Horatio Alger Award. Although he stepped down as CEO, he continues to serve as Chairman of the Board, ensuring that Masimo remains at the forefront of medical technology innovation.